A. Abdurrahman, M. A. S. Rijal, H. Yusuf, Norhayati, and G. Rizaldi, “In silico study of naringin as an anti-HER-2 receptor in the treatment of breast cancer”, Borneo J of Pharmascientech, vol. 8, no. 2, pp. 137-148, Oct. 2024.